# A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer

> **NCT01653574** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 28 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Famitinib Malate

## Key facts

- **NCT ID:** NCT01653574
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653574, "A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01653574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*